Figure 1.
Flowchart of the experiment.
Table 1.
Clinical Characteristics of the Patients.
Table 2.
Number of aberrantly expressed lncRNAs in microarray for three pairs of HCC and adjacent non-tumor tissues.
Table 3.
Number of aberrantly expressed mRNAs in microarray for three pairs of HCC and adjacent non-tumor tissues.
Figure 2.
Gene ontology (GO) enrichment analysis for differentially regulated mRNAs.
(A) GO analysis of mRNAs according to biological process. (B) GO analysis of mRNAs according to cellular component. (C) GO analysis of mRNAs according to molecular function.
Figure 3.
Distribution of eight lncRNAs in nineteen pairs of HCC samples.
Selected eight differentially expressed lncRNAs were validated by qPCR in 19 pairs of HCC samples. The heights of the columns in the chart represent the relative concentration of each lncRNA validated across the 19 patients.
Figure 4.
Consistency of lncRNAs and their nearby genes expression level.
Selected seven differentially expressed lncRNAs and their nearby genes were validated by qPCR in 19 pairs of HCC samples. The heights of the columns in the chart represent the log2 fold changes (T/N) in expression across the 19 patients for each of the seven lncRNAs validated.
Table 4.
Quantitative RT-PCR confirmation for selected forty lncRNAs.